Stromal reengineering to treat pancreas cancer
نویسندگان
چکیده
منابع مشابه
Stromal reengineering to treat pancreas cancer.
Pancreatic ductal adenocarcinoma co-opts multiple cellular and extracellular mechanisms to create a complex cancer organ with an unusual proclivity for metastasis and resistance to therapy. Cell-autonomous events are essential for the initiation and maintenance of pancreatic ductal adenocarcinoma, but recent studies have implicated critical non-cell autonomous processes within the robust desmop...
متن کاملEarly-stage ovarian cancer: to treat or not to treat.
Approximately one-third of patients with epithelial ovarian cancer present with localized disease confined to the ovaries or pelvis (International Federation of Gynecology and Obstetrics [FIGO] stages I and II). Although their long-term prognosis is better (10-year survival 50%–70%) than that of patients with advanced ovarian cancer (10-year survival 15%–25%), approximately 50% of women with ea...
متن کاملStage II colorectal cancer: to treat or not to treat.
The Oncologist 2005;10:332–334 www.TheOncologist.com Correspondence: Patrick G. Johnston, M.D., Ph.D., FRCP, FRCPI, Department of Oncology, Queen’s University Belfast, University Floor, Belfast City Hospital, Belfast BT9 7AB, Northern Ireland. Telephone: 44-28-90-263911; Fax: 44-28-90263744; e-mail: [email protected] Received March 8, 2005; accepted for publication March 18, 2005. ©AlphaMed Pr...
متن کاملDehydration in cancer patients: to treat or not to treat.
Many patients in the terminal phase of their illness experience reduced oral intake before death, due to causes related to their cancer or its treatment. When oral intake is not adequate, dehydration and malnutrition are the obvious results. But these terminally ill patients present a challenge to healthcare providers: to rehydrate these patients or not and, if so, how? Adequate hydration level...
متن کاملStage II Colon Cancer: To Treat or Not to Treat?
A diagnosis of cancer brings about many emotions because of the uncertainty it causes: uncertainty about side effects, the ability care for ourself, and most importantly, our life expectancy. But with the diagnosis of stage II colon cancer even selecting the best treatment can be fraught with uncertainty. This is the case when it comes to the question of whether to get chemotherapy or not follo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Carcinogenesis
سال: 2014
ISSN: 0143-3334,1460-2180
DOI: 10.1093/carcin/bgu115